Restricted stock granted in period, shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period LEASES Lessee, Operating Leases [Text Block] Ifetroban Clinical Ifetroban Clinical [Member] Ifetroban Clinical City Area Code City Area Code Cost of products sold Cost of Goods and Services Sold INVESTMENTS IN CASH EQUIVALENTS AND MARKETABLE SECURITIES Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Total costs and expenses Costs and Expenses Equity Components [Axis] Equity Components [Axis] Title of 12(b) Security Title of 12(b) Security Restricted Stock Restricted Stock [Member] Finished goods Inventory, Finished Goods, Net of Reserves Work in process - unlabeled vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Unlabeled Vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Unlabeled Vials Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Borrowings on line of credit Proceeds from (Repayments of) Lines of Credit Minimum Minimum [Member] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Balance Sheet Location [Domain] Balance Sheet Location [Domain] Proceeds from sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Repurchase of shares (in shares) Repurchase of shares (in shares) Stock Repurchased During Period, Shares Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Repayments on line of credit Repayments of Notes Payable Operating lease current liabilities Operating Lease, Liability, Current Acetadote Acetadote [Member] Acetadote Numerator: Numerator [Abstract] Numerator. Range [Domain] Statistical Measurement [Domain] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Schedule of Business Acquisitions by Acquisition, Contingent Consideration Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Line of Credit Line of Credit [Member] Net (income) loss at subsidiary attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Contribution of cash Subsidiary Investment, Cash Contribution Subsidiary Investment, Cash Contribution Net Revenues Revenues [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Nordic Nordic Group B.V. [Member] Nordic Group B.V. Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] SHAREHOLDERS' EQUITY AND DEBT Stockholders' Equity Note Disclosure [Text Block] Operating income (loss) Operating Income (Loss) Current assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets, Current Entity Address, Postal Zip Code Entity Address, Postal Zip Code Total current liabilities Liabilities, Current Finished goods inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finished Goods Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finished Goods Inventory Subsequent Event Type [Domain] Subsequent Event Type [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Products: Products [Abstract] Products. Statement of Stockholders' Equity [Abstract] Present value of remaining lease payments, percent Operating Lease, Weighted Average Discount Rate, Percent Net cash provided by (used in) operating activities from continuing operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and contingencies Commitments and Contingencies Grant Grant [Member] Repurchase of common shares Payments for Repurchase of Common Stock ASSETS Assets [Abstract] Restricted stock awards, vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period After 2023 Lessee, Operating Lease, Liability, to be Paid, after Year Five Change in fair value of contingent consideration included in operating expenses Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Share-based compensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Entity Shell Company Entity Shell Company Cover [Abstract] Accounts payable Accounts Payable, Current Document Type Document Type Vibativ VIBATIV [Member] VIBATIV Retained earnings (deficit) Retained Earnings (Accumulated Deficit) Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Total lease payments Lessee, Operating Lease, Liability, to be Paid Denominator: Denominator [Abstract] Denominator. Clinigen Clinigen Healthcare Limited [Member] Clinigen Healthcare Limited Loss Contingency Accrual [Roll Forward] Loss Contingency Accrual [Roll Forward] Equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Four Earnings (loss) per share attributable to common shareholders - Continuing operations - diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Goodwill Goodwill Financial consideration received in exchange for product license rights Proceeds from Sale of Intangible Assets Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Direct expenses Operating Expenses Earnings (loss) per share attributable to common shareholders - Discontinued operations - diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Document Quarterly Report Document Quarterly Report Title of Individual [Axis] Title of Individual [Axis] WinHealth HongKong WinHealth Pharma Group Co. Limited [Member] HongKong WinHealth Pharma Group Co. Limited Deferred tax assets, net Deferred Income Tax Assets, Net Investment through purchase of shares of CET Stock Subsidiary Investment, Purchase Of Shares Subsidiary Investment, Purchase Of Shares Total Lease, Liability Lease, Liability Level 2 Fair Value, Inputs, Level 2 [Member] Prepaid and other current assets Other Assets, Current Other revenue Other Products [Member] Other Products Inventories Total inventories classified as current Inventory, Net Net revenues Net revenues Revenue from Contract with Customer, Excluding Assessed Tax Second Amendment Second Amendment [Member] Second Amendment Inventory [Line Items] Inventory [Line Items] Lender Name [Axis] Lender Name [Axis] Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total Net income (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Vaprisol Vaprisol [Member] Vaprisol Earnings (loss) per share attributable to common shareholders - Discontinued operations - basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Business Acquisition [Axis] Business Acquisition [Axis] Entity Emerging Growth Company Entity Emerging Growth Company Shareholders' Equity (Textual) [Abstract] Shareholders Equity (Textual) [Abstract] Shareholders Equity. Statement [Line Items] Statement [Line Items] Unvested restricted shares (in shares) Stock Issued During Period, Shares, Acquisitions Credit Facility [Domain] Credit Facility [Domain] - diluted (in shares) Weighted-average shares outstanding – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Scenario, Forecast Forecast [Member] Earnings (loss) per share attributable to common shareholders - basic (in dollars per share) Earnings Per Share, Basic Noncash investment gains Unrealized Gain (Loss) on Investments Number of operating segments Number of Operating Segments Document Fiscal Period Focus Document Fiscal Period Focus Other current liabilities Other Current Liabilities [Member] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Inventory, Current [Table] Inventory, Current [Table] Statement [Table] Statement [Table] Selling and marketing Selling and Marketing Expense Range [Axis] Statistical Measurement [Axis] Common stock, par value (in dollars per share) Common Stock, No Par Value Credit Facility [Axis] Credit Facility [Axis] Discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Inventory Disposal Group, Including Discontinued Operation, Inventory Omeclamox-Pak Omeclamox-Pak [Member] Omeclamox-Pak Balance Sheet Location [Axis] Balance Sheet Location [Axis] Business Combinations [Abstract] Counterparty Name [Axis] Counterparty Name [Axis] Common stock—no par value; 100,000,000 shares authorized; 15,555,865 and 15,723,075 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively Common Stock, Value, Issued Maturity of Leases Liabilities at June 30, 2020 Lessee, Operating Lease, Liability, Payment, Due [Abstract] Commercial paper Commercial Paper [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Reconciliation of numerator and denominator Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cash payment of royalty during the period Payments for Royalties Share-based compensation (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Weighted-average shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Inventory Disclosure [Abstract] Aggregate amount The Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received The Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] COLLABORATIVE AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Amendment Flag Amendment Flag Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Total inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Present value of lease liabilities Operating Lease, Liability Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Segment Reporting [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Financial Instruments [Domain] Financial Instruments [Domain] Total shareholders’ equity Stockholders' Equity Attributable to Parent Percentage of tiered royalty payments (up to) Tiered Royalty Payments, Percentage Tiered Royalty Payments, Percentage Current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current Total consideration Business Combination, Consideration Transferred Other long-term liabilities Other Noncurrent Liabilities [Member] Total liabilities and equity Liabilities and Equity INCOME TAXES Income Tax Disclosure [Text Block] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Additions to intangible assets Payments to Acquire Intangible Assets Local Phone Number Local Phone Number General and administrative General and Administrative Expense Line of credit, maximum borrowing capacity upon satisfaction of certain conditions Line Of Credit Facility, Maximum Borrowing Capacity Upon Satisfaction Of Certain Conditions Line Of Credit Facility, Maximum Borrowing Capacity Upon Satisfaction Of Certain Conditions Financial Instrument [Axis] Financial Instrument [Axis] Common stock available for purchase through restricted stock awards and options (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Pinnacle Bank Pinnacle Bank [Member] Pinnacle Bank Statement of Cash Flows [Abstract] Dilutive effect of other securities (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Equity Component [Domain] Equity Component [Domain] Summary of net revenue Revenue from External Customers by Products and Services [Table Text Block] Vested common stock, value Stock Issued During Period, Value, Acquisitions Entity Address, Address Line One Entity Address, Address Line One Other long-term liabilities Other Long Term Obligations, Excluding Current Portion Other Long Term Obligations, Excluding Current Portion Entity Address, Address Line Two Entity Address, Address Line Two 2021 Lessee, Operating Lease, Liability, to be Paid, Year Two Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Kristalose Kristalose [Member] Kristalose Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Property and equipment, net Property, Plant and Equipment, Net Amortization Amortization of Intangible Assets Net income (loss) attributable to common shareholders Net income (loss) attributable to common shareholders Net Income (Loss) Attributable to Parent Entity Address, State or Province Entity Address, State or Province Line of Credit Facility [Table] Line of Credit Facility [Table] Net changes in assets and liabilities affecting operating activities: Increase (Decrease) in Operating Capital [Abstract] Other current liabilities Other Liabilities, Current Entity Current Reporting Status Entity Current Reporting Status 2022 Lessee, Operating Lease, Liability, to be Paid, Year Three 2020 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Other assets Other Assets, Noncurrent INVENTORIES Inventory Disclosure [Text Block] Total intangibles and goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles and Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles and Goodwill Lease Position Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee REVENUES Segment Reporting Disclosure [Text Block] Leases [Abstract] Total assets Assets Scenario [Axis] Scenario [Axis] Consigned inventory Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Total current assets Assets, Current Net operating loss carryforwards Operating Loss Carryforwards Earnings (loss) per share attributable to common shareholders Earnings Per Share [Abstract] Discontinued operations income Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Intangible assets, net Finite-Lived Intangible Assets, Net Subsequent Event Type [Axis] Subsequent Event Type [Axis] Investments, Debt and Equity Securities [Abstract] Entity Small Business Entity Small Business Shareholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Entity Interactive Data Current Entity Interactive Data Current Interest expense Interest Expense Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Raw materials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Raw Materials Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Raw Materials Inventory Depreciation and amortization expense Depreciation, Depletion and Amortization Entity Filer Category Entity Filer Category Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Entity Address, City or Town Entity Address, City or Town Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Common stock Common Stock [Member] Product and Service [Domain] Product and Service [Domain] Repurchase of subsidiary shares from noncontrolling interest Payments for Repurchase of Redeemable Noncontrolling Interest Level 1 Fair Value, Inputs, Level 1 [Member] Cash payments for return of shares Subsidiary Investment, Payments For Return Of Capital Subsidiary Investment, Payments For Return Of Capital Inventories Increase (Decrease) in Inventories Decrease in non-cash contingent consideration Excess Tax Benefit from Share-based Compensation, Operating Activities Document Fiscal Year Focus Document Fiscal Year Focus Raw materials and work in process Inventory, Raw Materials, Net of Reserves Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Interest rate spread Debt Instrument, Interest Rate, Stated Percentage Inventory, Gross, Total Inventory, Gross Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Earnings (loss) per share attributable to common shareholders - Continuing operations - basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ADDITIONS AND RETURN OF PRODUCT RIGHTS Business Combination Disclosure [Text Block] Repurchase of subsidiary shares from noncontrolling interests Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Common stock, shares outstanding (in shares) Balance, Beginning of Period (in shares) Balance, End of Period (in shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Schedule of Maturity of Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Revolving Credit Facility Revolving Credit Facility [Member] - basic (in shares) Weighted-average shares outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Costs and expenses: Costs and Expenses [Abstract] Research and development Research and Development Expense Subsequent Events [Abstract] Subsequent Event Subsequent Event [Member] Federal Domestic Tax Authority [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Contingent consideration earned and accrued in operating expenses Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses Methotrexate Methotrexate [Member] Methotrexate [Member] Total equity Balance, Beginning of Period Balance, End of Period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest ORGANIZATION AND BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Liability recorded Business Combination, Consideration Transferred, Liabilities Incurred Revenue Revenues Document Period End Date Document Period End Date Income tax (expense) benefit Income Tax Expense (Benefit) Entity Registrant Name Entity Registrant Name Income Statement [Abstract] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Purchases of marketable securities Payments to Acquire Marketable Securities Relationship to Entity [Domain] Title of Individual [Domain] Operating lease noncurrent liabilities Operating Lease, Liability, Noncurrent Earnings (loss) per share attributable to common shareholders - diluted (in dollars per share) Earnings Per Share, Diluted Intellectual property amortizable intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Work in process - validation vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Validation Vials Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Work in Process Inventory, Validation Vials Cash paid for acquisition Payment to acquire business upon closing Payment to acquire business upon closing Payments to Acquire Businesses, Gross Discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Use of Estimates Use of Estimates, Policy [Policy Text Block] Current assets: Assets, Current [Abstract] Interest income Investment Income, Interest Income Tax Authority [Domain] Income Tax Authority [Domain] Other current assets and other assets Increase (Decrease) in Other Operating Assets Equity and Debt [Abstract] Equity and Debt [Abstract] Cash payment during 2019 Other Payments to Acquire Businesses Deferred tax expense Deferred Income Tax Expense (Benefit) Revolving line of credit Long-term Line of Credit, Noncurrent Fair value of contingent consideration - net sales royalty Payments for Contingent Consideration Payments for Contingent Consideration Line of credit, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Scenario, Unspecified [Domain] Scenario [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Additions to property and equipment Payments to Acquire Property, Plant, and Equipment Accounts payable and other current liabilities IncreaseDecreaseInCurrentOperatingLiabilities Maximum Maximum [Member] Noncash interest expense Amortization of Debt Issuance Costs Security Exchange Name Security Exchange Name Noncontrolling interests Noncontrolling Interest [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Entity Tax Identification Number Entity Tax Identification Number Gloria Pharmaceuticals Gloria Pharmaceuticals [Member] Gloria Pharmaceuticals Additional liability Beginning balance Ending balance Business Combination, Contingent Consideration, Liability Retained earnings Retained Earnings [Member] Cash payment of contingent consideration Payment for Contingent Consideration Liability, Financing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Director Director [Member] Repurchase outstanding common shares Stock Repurchase Program, Authorized Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Net income (loss) Net income (loss) Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Equity Award [Domain] Award Type [Domain] Income (loss) from continuing operations before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Trading Symbol Trading Symbol Document Transition Report Document Transition Report Fair value of marketable securities, by type Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Inventory Schedule of Inventory, Current [Table Text Block] Marketable securities Debt Securities, Trading, and Equity Securities, FV-NI Line of credit, unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Repurchase of common shares Repurchase of shares, value Stock Repurchased During Period, Value Share-based compensation Share-based Payment Arrangement, Noncash Expense Caldolor Caldolor [Member] Caldolor Non-current inventories Inventory, Noncurrent Inventory, Noncurrent EARNINGS (LOSS) PER SHARE Earnings Per Share [Text Block] Inventory Inventory, Net, Items Net of Reserve Alternative [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Current liabilities: Liabilities, Current [Abstract] Shelf Registration, sale of corporate securities (up to) StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities Operating Segments Segment Reporting, Policy [Policy Text Block] Conversion of intercompany loans payable Subsidiary Investment, Conversion Of Intercompany Loans Payable Subsidiary Investment, Conversion Of Intercompany Loans Payable Income Tax Contingency [Table] Income Tax Contingency [Table] Recent Accounting Guidance New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract]